CO4810231A1 - Nuevas sulfonamidas naftil- y anilido - substituidas - Google Patents

Nuevas sulfonamidas naftil- y anilido - substituidas

Info

Publication number
CO4810231A1
CO4810231A1 CO99003181A CO99003181A CO4810231A1 CO 4810231 A1 CO4810231 A1 CO 4810231A1 CO 99003181 A CO99003181 A CO 99003181A CO 99003181 A CO99003181 A CO 99003181A CO 4810231 A1 CO4810231 A1 CO 4810231A1
Authority
CO
Colombia
Prior art keywords
chain
alkyl
halogen
carbon atoms
branched
Prior art date
Application number
CO99003181A
Other languages
English (en)
Spanish (es)
Inventor
Wolfgang Bender
Jurgen Reefschlager
Peter Eckenberg
Siegfried Goldmann
Michael Harter
Sabine Hallenberger
Jorg Trappe
Olaf Webwer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CO4810231A1 publication Critical patent/CO4810231A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO99003181A 1998-01-23 1999-01-21 Nuevas sulfonamidas naftil- y anilido - substituidas CO4810231A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19802439 1998-01-23

Publications (1)

Publication Number Publication Date
CO4810231A1 true CO4810231A1 (es) 1999-06-30

Family

ID=7855411

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99003181A CO4810231A1 (es) 1998-01-23 1999-01-21 Nuevas sulfonamidas naftil- y anilido - substituidas

Country Status (30)

Country Link
US (1) US6417181B1 (enExample)
EP (1) EP1049666B1 (enExample)
JP (1) JP2002501043A (enExample)
KR (1) KR20010034321A (enExample)
CN (1) CN1294578A (enExample)
AR (1) AR016978A1 (enExample)
AT (1) ATE242207T1 (enExample)
AU (1) AU2420799A (enExample)
BG (1) BG104617A (enExample)
BR (1) BR9907738A (enExample)
CA (1) CA2318182A1 (enExample)
CO (1) CO4810231A1 (enExample)
DE (1) DE59905829D1 (enExample)
EE (1) EE200000432A (enExample)
ES (1) ES2201666T3 (enExample)
GT (1) GT199900010A (enExample)
HR (1) HRP20000532A2 (enExample)
HU (1) HUP0200918A2 (enExample)
ID (1) ID25448A (enExample)
IL (1) IL137159A0 (enExample)
NO (1) NO20003601L (enExample)
NZ (1) NZ505900A (enExample)
PE (1) PE20000181A1 (enExample)
PL (1) PL341815A1 (enExample)
SK (1) SK11012000A3 (enExample)
SV (1) SV1999000006A (enExample)
TR (1) TR200002140T2 (enExample)
TW (1) TW461880B (enExample)
WO (1) WO1999037609A1 (enExample)
ZA (1) ZA99473B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19919793A1 (de) * 1999-04-30 2000-11-02 Bayer Ag Neue Sulfonamide
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
DE19934295A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Kristallmodifikation III von N-(4-(5-Dimethylamino-naphthalin-1-sulfonyl-amino)-phenyl)-3-hydroxy-2,2-dimethyl-propionamid
DE19934321A1 (de) * 1999-07-21 2001-01-25 Bayer Ag Naphthyl-substituierte Sulfonamide
EP1402890B1 (en) * 2001-06-08 2008-01-09 Institute of Medicinal Molecular Design, Inc. Sulfonamide derivatives
GB2403474B (en) * 2002-04-18 2006-10-11 Inst Med Molecular Design Inc Amide derivatives
TW200510311A (en) 2002-12-23 2005-03-16 Millennium Pharm Inc CCr8 inhibitors
EP1590327A1 (en) 2002-12-23 2005-11-02 Millennium Pharmaceuticals, Inc. Ccr8 inhibitors
US7491827B2 (en) * 2002-12-23 2009-02-17 Millennium Pharmaceuticals, Inc. Aryl sulfonamides useful as inhibitors of chemokine receptor activity
US7425527B2 (en) 2004-06-04 2008-09-16 The Procter & Gamble Company Organic activator
RU2452490C1 (ru) * 2010-12-27 2012-06-10 Виктор Вениаминович Тец Лекарственное средство с активностью против семейства герпес-вирусов
AU2013257951A1 (en) 2012-05-11 2015-01-22 Akron Molecules Ag Use of compounds for the treatment of pain
RU2530587C1 (ru) 2013-06-07 2014-10-10 Виктор Вениаминович Тец Способ лечения заболеваний кожи и слизистых оболочек, вызываемых вирусами простого герпеса 1-го и 2-го типов
RU2605602C1 (ru) 2015-09-15 2016-12-27 Общество с ограниченной ответственностью "Новые Антибиотики" Способ получения натриевой соли (2,6-дихлорфенил)амида карбопентоксисульфаниловой кислоты
CN112062901B (zh) * 2020-08-14 2023-03-21 合肥工业大学 一种螺旋荧光异腈共聚物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2423572A (en) * 1946-05-03 1947-07-08 Du Pont Naphtholsulfonamidobenzaldehydes and acetals thereof
US2949479A (en) * 1954-06-17 1960-08-16 Dainippon Pharmaceutical Co Acyl derivatives of aminonaphthalene-sulfonamide
US3925347A (en) 1967-07-24 1975-12-09 Polaroid Corp Processes of synthesizing azo compounds
US3482971A (en) 1967-07-24 1969-12-09 Polaroid Corp Scavengers for oxidized developing agent
US4035401A (en) 1970-03-30 1977-07-12 Polaroid Corporation Intermediates for photographic dyes
JPS5499433A (en) 1978-01-20 1979-08-06 Konishiroku Photo Ind Co Ltd Dye image formation method
EP0284130B1 (en) 1987-03-19 1991-06-26 Agfa-Gevaert N.V. Organic compounds for use in a dye diffusion transfer process and photographic elements incorporating them
AU5175490A (en) * 1989-02-27 1990-09-26 Du Pont Merck Pharmaceutical Company, The Novel sulfonamides as radiosensitizers
DE4331134A1 (de) 1993-09-14 1995-03-16 Bayer Ag Neue antiviral wirksame Pseudopeptide
EP0684515A1 (en) 1994-05-27 1995-11-29 Eastman Kodak Company Photographic element and process incorporating a high dye-yield image coupler providing improved granularity

Also Published As

Publication number Publication date
HRP20000532A2 (en) 2001-02-28
PE20000181A1 (es) 2000-04-12
BG104617A (en) 2001-04-30
WO1999037609A1 (de) 1999-07-29
PL341815A1 (en) 2001-05-07
AR016978A1 (es) 2001-08-01
EE200000432A (et) 2001-12-17
IL137159A0 (en) 2001-07-24
NO20003601L (no) 2000-09-14
ATE242207T1 (de) 2003-06-15
CN1294578A (zh) 2001-05-09
SV1999000006A (es) 2000-10-09
ES2201666T3 (es) 2004-03-16
GT199900010A (es) 2000-07-15
HUP0200918A2 (en) 2002-09-28
ID25448A (id) 2000-10-05
TR200002140T2 (tr) 2000-12-21
KR20010034321A (ko) 2001-04-25
SK11012000A3 (sk) 2001-01-18
TW461880B (en) 2001-11-01
EP1049666A1 (de) 2000-11-08
AU2420799A (en) 1999-08-09
DE59905829D1 (de) 2003-07-10
NO20003601D0 (no) 2000-07-13
EP1049666B1 (de) 2003-06-04
US6417181B1 (en) 2002-07-09
ZA99473B (en) 1999-07-27
BR9907738A (pt) 2000-10-17
NZ505900A (en) 2002-02-01
CA2318182A1 (en) 1999-07-29
JP2002501043A (ja) 2002-01-15

Similar Documents

Publication Publication Date Title
CO4600675A1 (es) Derivados de oxalilamino-benzofurano y benzotienilo
CO4900059A1 (es) 3- ureido-piridofuranos y- piridotiofenos
CO5021127A1 (es) Nuevas dihidropirimidas
BR0213981A (pt) Fotoiniciadores difuncionais
LTC1482932I2 (lt) N3 alkilinto benzimidazolo dariniai kaip MEK inhibitoriai
AR009212A1 (es) Un derivado de 3-piperidil-4-oxoquinazolina; una composicion farmaceutica, un inhibidor de la proteina de transferencia de los trigliceridos microsomal(mtp) y un agente terapeutico o preventivo para la hiperlipemia o la arteriosclerosis que lo contienen
ATE227264T1 (de) Metalloproteinase-inhibitoren
DK1244642T3 (da) Substituerede oxazol- og thiazolderivater som HPPAR-alfa-aktivatorer
HN1997000027A (es) Derivados de 6-fenil piridil - 2 amina
CO5310534A1 (es) Nuevos derivados de androstano anti-inflamatorios
AR034282A1 (es) Derivados de difenilazetidinona, medicamentos que contienen estos compuestos, procedimiento para su preparacion, y su utilizacion para la preparacion de medicamentos
DK1001930T3 (da) N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser
CY2012005I2 (el) Συνθεσεις και μεθοδοι για σταθεροποιηση τρανσθυρετινης και παρεμποδιση εσφαλμενης αναδιπλωσης τρανσθυρετινης
NO20022988L (no) Vedvarende frigivelse (med dybdevirkning) av syklooksygenase- 2-inhibitor
CO4700523A1 (es) Purin-6-onas bisustituidas en 2,9
CR10553A (es) Derivados novedosos de aminopiridina que tienen accion inhibidora selectiva sobre aurora a
IS2287B (is) Nýjar afleiður og hliðstæður af galantamíni
AR016978A1 (es) Sulfonamidas naftil- y anilidido-substituidas, un proceso para su preparacion, uso de las mismas para la fabricacion de medicamentos y medicamentos que loscontienen
CY1108793T1 (el) Καμπτοθεκινες με τροποποιημενο λακτονικο δακτυλιο
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
PA8483901A1 (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida
CY1106692T1 (el) Παραγωγα του αλοξενοϋλ-κυκλοπροπαν-1-καρβοξυλικου οξεος
CO5580821A2 (es) 4-cetolactamas y -lactonas 3-fenil-3-substituidas, espirociclicas
SV2002000244A (es) Metodos y compuestos para inhibir mrp1 ref.x-13353
BR0113243A (pt) Composição lubrificante